Skip to main content
. 2017 Feb 22;19(2):292–305. doi: 10.22074/cellj.2016.490

Table 4.

Effects of T and VitE on ATZ-induced cellular apoptosis


Control-sham ATZ-induced ATZ+VitE ATZ+T ATZ+VitE+T

Total Sertoli cells 41.33 ± 1.52a 22.64 ± 1.22b 35.00 ± 2.01c 40.37 ± 2.11a,d 40.70 ± 2.56d
Apoptotic Sertoli cells 1.38 ± 0.42a 17.25 ± 0.95b 13.00 ± 2.16c 12.75 ± 0.95c 7.25 ± 1.70d
TSE/TASE (%) 3.39 76.1 34.1 31.58 17.81
Total Leydig cells 35.33 ± 2.08a 18.33 ± 1.52b 30.64 ± 2.08c 29.66 ± 1.52c 35.58 ± 1.43d
Apoptotic Leydig cells 0.90 ± 0.27a 10.75 ± 0.95b 8.25 ± 0.50c 8.86 ± 0.27c 5.03 ± 0.76d
TL/TAL (%) 2.5 58.6 26.6 27.81 15.4
Total spermatogonia cells 51.75 ± 4.99a 33.75 ± 2.62b 40.82 ± 1.96c 38.25 ± 1.06c 45.50 ± 2.64d
Apoptotic spermatogonia cells 2.00 ± 1.41a 26.25 ± 1.70b 18.75 ± 0.95c 21.00 ± 2.00c 12.14 ± 1.82d
TS/TAS (%) 3.8 77.7 46.01 54.9 26.68

All data are presented in mean ± SD and %.

a vs. b; Significant at P<0.05, c, d vs. b; Significant at P<0.05, ATZ; Atrazine, VitE; Vitamin E, T; Testosterone, TSE; Total Sertoli cells, TASE; Total apoptotic Sertoli cells, TL; Total Leydig cells, TAL; Total apoptotic Leydig cells, TS; Total spermatogonia cells, and TAS; Total apoptotic spermatogonia cells.